Open AccessMaculopapular eruption and fever due to lamotrigine followed by subsiding flare‐ups
Author(s) -
Valerieva Anna,
Staevska Maria,
Dimitrov Vasil,
Popov Todor
Publication year - 2015
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-5-s1-p13
Subject(s) - medicine , rash , lamotrigine , drug eruption , maculopapular rash , dermatology , methylprednisolone , anesthesia , epilepsy , drug , pharmacology , psychiatry
Lamotrigine (LTG), an aromatic antiepileptic drug, is mainly used to manage epilepsy and bipolar / mood disorders. Skin rashes are the most common adverse reaction to this drug that typically develop in the first 8 weeks of treatment.